Article

Magnetic resonance imaging-based biodistribution of theranostic AGuIX nanoparticles in the NANORAD 2 clinical trial for brain metastases

2025-12-30

Abstract excerpt

<title>Abstract</title> <p>Purpose AGuIX nanoparticles are promising theranostic agents that selectively accumulate in brain metastases via the enhanced permeability and retention effect, potentially improving radiotherapy efficacy. This ancillary analysis of the NANORAD2 trial investigates AGuIX biodistribution in patients with multiple brain metastases undergoing whole-brain radiotherapy (WBRT). Methods Signa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ec4eecb3-9e80-5ee5-8269-bb23fc81e9e2
DOI: 10.21203/rs.3.rs-8401098/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Magnetic resonance imaging-based biodistribution of theranostic AGuIX nanoparticles in the NANORAD 2 clinical trial for brain metastasesDOI 10.21203/rs.3.rs-8401098/v1Read

18F-AlF-FAPI nanotracer visualized the quick response of sarcoma to radiotherapy by PET/CTSemantic proximity Read

Biomedical Applications of Targeted Drug Delivery, Nanotheranostic and Nuclear MedicineSemantic proximity Read

Albumin-binding dendrimer-conjugated siRNA enables safe and effective gene silencing throughout the central nervous systemSemantic proximity Read

Development of Integrin α5β1-targeted PET/NIR imaging probes for glioblastoma intraoperative navigation and intracavity targeted radionuclide therapySemantic proximity Read

Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy. Implications for Radiopharmaceutical Repurposing (Beyond Oncology)Semantic proximity Read

Therapeutic Nucleus-Access BNCT Drug Combined CD47-Targeting Gene Editing in GlioblastomaSemantic proximity Read

Novel Multifunctional NIR-II Aggregation-Induced Emission Nanoparticles Assisted Intraoperative Identification and Elimination of Residual TumorSemantic proximity Read

Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity.Semantic proximity Read

Targeted Treatment of Brain Metastases.Semantic proximity Read

Transport vehicle–mediated TREM2 PET maps myeloid cells in the glioblastoma microenvironmentSemantic proximity Read

ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls gliomaSemantic proximity Read

Assessing Tumor Microenvironment Characteristics and Stratifying EPR with a Nanobubble Companion Nanoparticle via Contrast-Enhanced Ultrasound ImagingSemantic proximity Read